Numerion Labs specializes in AI-based drug discovery services
Numerion Labs specializes in AI-based drug discovery services. The company develops small-molecule drug candidates using atomnet technology, which employs deep learning for structure-based drug design. It collaborates with over 250 partners, including pharmaceutical and biotechnology companies, to address various disease targets.